サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1463115

オキシトシン市場、シェア、規模、動向、産業分析レポート：適応症別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
オキシトシン市場、シェア、規模、動向、産業分析レポート：適応症別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のオキシトシン市場規模は2032年までに1億9,302万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

同市場は、安全で効果的な産科医療を優先する妊産婦ヘルスケアへの取り組みの増加によって成長を遂げています。陣痛誘発や産後出血の管理に不可欠なオキシトシンは、妊産婦ヘルスケアにおいて極めて重要な役割を果たしています。妊産婦死亡率を減少させ、質の高いヘルスケアへのアクセスを強化し、産科診療を改善するための努力は、オキシトシン注射の需要増加に寄与しています。さらに、妊産婦保健プログラムにおける必須医薬品の利用可能性を確保する努力が市場を後押ししており、特に妊産婦保健の大きな課題に直面している地域において、妊産婦の転帰と産科医療全般を強化する上でオキシトシンが重要な役割を担っていることが強調されています。

帝王切開分娩の有病率の増加が市場を後押ししています。オキシトシンは、予定帝王切開や緊急帝王切開の際に陣痛を促進または開始する上で重要な役割を果たすからです。世界的に帝王切開分娩の数が増加しているため、陣痛促進や術後の子宮収縮のためのオキシトシン注射の必要性が高まっています。オキシトシンは産後出血を予防し、帝王切開時の安全な分娩を促進するために不可欠です。

オキシトシンは、死亡率の主な原因であるPPHを予防・管理する上で極めて重要な役割を果たします。過剰出血をコントロールするオキシトシン注射の救命効果に関するヘルスケア提供者や政策立案者の意識向上。PPH予防の重要性を強調する母性健康プログラム、キャンペーン、健康イニシアティブは、オキシトシン注射の採用をさらに刺激します。ヘルスケアシステムは、PPH予防におけるオキシトシンの役割により、死亡率の低下に役立っています。

オキシトシン市場レポートハイライト

産後セグメントが最大のシェアを獲得、これは妊産婦の死亡率と合併症の増加によるもの

病院部門は、あらゆる医療設備を完備しているため、市場を独占している

出産数の増加と妊産婦の健康に関する意識の高まりにより、APAC地域が最速で成長する見込み

主な市場企業は、ファイザー、ノバルティス、フェリング、フレゼニウス・カビ、ヒクマ・ファーマシューティカルズ、エンド・インターナショナル、サン・ファーマシューティカルズ、ユーハン・コーポレーションなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のオキシトシン市場の洞察

  • オキシトシン市場- 業界スナップショット
  • オキシトシン市場力学
    • 促進要因と機会
      • 中絶と望まない妊娠の増加
      • 帝王切開出産の増加
    • 抑制要因と課題
      • 市場へのアクセスと成長に影響を与える厳しい規制
  • PESTLE分析
  • オキシトシン業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のオキシトシン市場、適応症別

  • 主な調査結果
  • イントロダクション
  • 出産前
  • 産後

第6章 オキシトシンの世界市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • ドラッグストア
  • オンライン薬局

第7章 世界のオキシトシン市場、地域別

  • 主な調査結果
  • イントロダクション
    • オキシトシン市場評価、地域別、2019年～2032年
  • オキシトシン市場-北米
    • 北米：オキシトシン市場、流通チャネル別、2019年～2032年
    • 北米：オキシトシン市場、適応症別、2019年～2032年
    • オキシトシン市場-米国
    • オキシトシン市場- カナダ
  • オキシトシン市場- 欧州
    • 欧州：オキシトシン市場、流通チャネル別、2019年～2032年
    • 欧州：オキシトシン市場、適応症別、2019年～2032年
    • オキシトシン市場- 英国
    • オキシトシン市場- フランス
    • オキシトシン市場- ドイツ
    • オキシトシン市場- イタリア
    • オキシトシン市場- スペイン
    • オキシトシン市場- オランダ
    • オキシトシン市場- ロシア
  • オキシトシン市場- アジア太平洋
    • アジア太平洋：オキシトシン市場、流通チャネル別、2019年～2032年
    • アジア太平洋：オキシトシン市場、適応症別、2019年～2032年
    • オキシトシン市場- 中国
    • オキシトシン市場- インド
    • オキシトシン市場- マレーシア
    • オキシトシン市場- 日本
    • オキシトシン市場- インドネシア
    • オキシトシン市場- 韓国
  • オキシトシン市場-中東・アフリカ
    • 中東・アフリカ：オキシトシン市場、流通チャネル別、2019年～2032年
    • 中東・アフリカ：オキシトシン市場、適応症別、2019年～2032年
    • オキシトシン市場- サウジアラビア
    • オキシトシン市場-UAE
    • オキシトシン市場- イスラエル
    • オキシトシン市場- 南アフリカ
  • オキシトシン市場-ラテンアメリカ
    • ラテンアメリカ：オキシトシン市場、流通チャネル別、2019年～2032年
    • ラテンアメリカ：オキシトシン市場、適応症別、2019年～2032年
    • オキシトシン市場- メキシコ
    • オキシトシン市場- ブラジル
    • オキシトシン市場- アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/展示会

第9章 企業プロファイル

  • Pfizer Inc
  • Novartis AG
  • Ferring B.V
  • Fresenius Kabi LLC
  • Hikma Pharmaceuticals PLC
  • Endo International plc.（Par Sterile Products, LLC）
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Wockhardt Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Yuhan Corporation
図表

List of Tables

  • Table 1 Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 2 Global Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 3 Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 5 North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 6 U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 7 U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 8 Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 9 Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 10 Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 12 UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 13 UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 14 France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 15 France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 16 Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 18 Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 19 Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 20 Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 21 Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 22 Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 25 Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 28 China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 30 India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 31 India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 32 Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 33 Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 34 Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 37 Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 38 South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 39 South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 44 UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 45 UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 46 Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 48 South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 49 South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 50 Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 51 Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 52 Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 54 Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 55 Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 56 Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 57 Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Oxytocin Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Distribution Channel
  • Figure 7 Global Oxytocin Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 8 Market by Indication
  • Figure 9 Global Oxytocin Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 10 Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Oxytocin Market
目次
Product Code: PM4789

The global oxytocin market size is expected to reach USD 193.02 million by 2032, according to a new study by Polaris Market Research. The report "Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is experiencing growth driven by increasing initiatives in maternal healthcare, which prioritize safe and effective obstetric care. Oxytocin, essential for labor induction and managing postpartum haemorrhage, plays a pivotal role in maternal healthcare. Efforts to decrease maternal mortality rates, enhance access to quality healthcare, and improve obstetric practices contribute to the rising demand for oxytocin injections. Additionally, endeavors to ensure the availability of essential medicines in maternal health programs are propelling the market, underscoring oxytocin's crucial role in enhancing maternal outcomes and overall obstetric care, particularly in regions facing significant maternal healthcare challenges.

The increasing prevalence of cesarean section deliveries is propelling the market, as oxytocin plays a critical role in enhancing or initiating labor during scheduled and emergency cesarean sections. With a growing number of cesarean deliveries worldwide, the need for oxytocin injections for labor enhancement or post-surgery uterine contraction is escalating. Oxytocin is vital for preventing postpartum haemorrhage and facilitating safe deliveries during cesarean sections.

Oxytocin serves as a crucial intervention in preventing & managing PPH, a primary cause of mortality. Awareness among the healthcare providers & policymakers regarding the life-saving impact of the oxytocin injections in controlling the excessive bleeding. Maternal health programs, campaigns, & health initiatives that emphasize the importance of PPH prevention further stimulate the adoption of oxytocin injections. Healthcare systems helps in reducing the mortality rates, owing to the oxytocin role in preventing the PPH.

Oxytocin Market Report Highlights

Postpartum segment garnered the largest share, owing to rise in maternal mortalities and concerned complications

Hospital segment dominated the market, as they are fully equipped with all medical facilities

APAC will grow at the fastest rate, owing to rise in child births and awareness regarding maternal health

The key market players include Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceutical and Yuhan Corporation

Polaris Market Research has segmented the oxytocin market report based on indication, distribution channel, and region:

Oxytocin, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Antepartum
  • Postpartum

Oxytocin, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies

Oxytocin, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oxytocin Market Insights

  • 4.1. Oxytocin Market - Industry Snapshot
  • 4.2. Oxytocin Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in abortion and unwanted pregnancies
      • 4.2.1.2. Rise in cesarean deliveries
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulations impacting market access and growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Oxytocin Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oxytocin Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oxytocin, by Indication, 2019-2032 (USD Million)
  • 5.3. Antepartum
    • 5.3.1. Global Oxytocin Market, by Antepartum, by Region, 2019-2032 (USD Million)
  • 5.4. Postpartum
    • 5.4.1. Global Oxytocin Market, by Postpartum, by Region, 2019-2032 (USD Million)

6. Global Oxytocin Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Oxytocin Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
  • 6.4. Drug Stores
    • 6.4.1. Global Oxytocin Market, by Drug Stores, by Region, 2019-2032 (USD Million)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Oxytocin Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)

7. Global Oxytocin Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Oxytocin Market - North America
    • 7.3.1. North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.3.2. North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.3.3. Oxytocin Market - U.S.
      • 7.3.3.1. U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.3.4. Oxytocin Market - Canada
      • 7.3.4.1. Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.4. Oxytocin Market - Europe
    • 7.4.1. Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.4.2. Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.3. Oxytocin Market - UK
      • 7.4.3.1. UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.4. Oxytocin Market - France
      • 7.4.4.1. France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.4.2. France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.5. Oxytocin Market - Germany
      • 7.4.5.1. Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.6. Oxytocin Market - Italy
      • 7.4.6.1. Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.7. Oxytocin Market - Spain
      • 7.4.7.1. Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.8. Oxytocin Market - Netherlands
      • 7.4.8.1. Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.9. Oxytocin Market - Russia
      • 7.4.9.1. Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.5. Oxytocin Market - Asia Pacific
    • 7.5.1. Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.3. Oxytocin Market - China
      • 7.5.3.1. China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.3.2. China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.4. Oxytocin Market - India
      • 7.5.4.1. India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.4.2. India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.5. Oxytocin Market - Malaysia
      • 7.5.5.1. Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.6. Oxytocin Market - Japan
      • 7.5.6.1. Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.7. Oxytocin Market - Indonesia
      • 7.5.7.1. Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.8. Oxytocin Market - South Korea
      • 7.5.8.1. South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.6. Oxytocin Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.3. Oxytocin Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.4. Oxytocin Market - UAE
      • 7.6.4.1. UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.5. Oxytocin Market - Israel
      • 7.6.5.1. Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.6. Oxytocin Market - South Africa
      • 7.6.6.1. South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.7. Oxytocin Market - Latin America
    • 7.7.1. Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.7.3. Oxytocin Market - Mexico
      • 7.7.3.1. Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.7.4. Oxytocin Market - Brazil
      • 7.7.4.1. Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.7.5. Oxytocin Market - Argentina
      • 7.7.5.1. Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Pfizer Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Novartis AG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Ferring B.V
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Fresenius Kabi LLC
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Hikma Pharmaceuticals PLC
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Endo International plc. (Par Sterile Products, LLC)
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Teva Pharmaceutical Industries Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Mylan N.V.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Wockhardt Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Sun Pharmaceutical Industries Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Yuhan Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development